Erector Spine Plane Block Versus Local Infiltration Anaesthesia For Transforaminal Percutaneous Endoscopic Discectomy
CompletedNot applicableNCT05483647
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The main aim of our study was to test the hypothesis that Erector spine plane block (ESP) with sedation will provide the similar employment of fentanyl and propofol during surgery as an infiltrative local anaesthesia with sedation. The primary endpoint was the quantity of fentanyl and propofol during surgery.
Study details
- Official title
- Erector Spine Plane Block as a Component of General Anesthesia in Spine Surgery
- Conditions
- Acute Pain
- Chronic Pain
- Postoperative Pain
- Anesthesia
- Regional Anesthesia Morbidity
- Anesthesia, Local
- Anesthesia Complication
- Hyperalgesia
- Intraoperative Complications
- Intraoperative Neurological Injury
- Intraoperative Injury
- Postoperative Nausea and Vomiting
- Postoperative Cognitive Dysfunction
- Neuropathic Pain
- Interventions
- Procedure: Local infiltrative anaesthesia
- Procedure: Erector spine plane block
- Sponsor
- Lviv National Medical University
- Start date
- 2021-01-01
- Primary completion
- 2022-01-01
- Sex
- All
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Ukraine
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: informed consent of the patient to participate in the study, intervertebral hernia that require transforaminal percutaneous endoscopic discectomy, and the absence of known allergies to local anaesthetics. Exclusion Criteria: refusal to participate in the study both at the beginning of the study and at any stage of the study, physical status according to the ASA classification III and more, age more than 50 years old, body mass index (BMI) more than 30 kg/m2.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05483647